Gibbeum General Hospital
Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.
He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.
He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.
Dr. Park Sundo is a specialist in gastrointestinal and general surgery at Naeun Hospital. His expertise includes colorectal, proctology, breast, thyroid, laparoscopic, biliary, pancreatic, and pediatric surgery.
Key treatments include proctologic surgery, such as hemorrhoidectomy and care for hemorrhoids and anal fistula. He performs laparoscopic surgery for gallstones (cholelithiasis) and appendicitis. His oncology care covers gastric and colorectal cancer. He also performs hernia repair. Breast and thyroid care includes treatment of tumors and Mammotome biopsy. He treats varicose veins and severe burns. Pediatric surgery includes hernia repair and general pediatric procedures.
Dr. Kim Taekhyeon is a gastrointestinal surgeon and the Chief of Gastrointestinal Surgery at Naeun Hospital. He received his M.D. and M.S. from Chung-Ang University College of Medicine. He completed an internship at Sungae Hospital and a general surgery residency at Chung-Ang University Hospital. He then finished a fellowship in gastrointestinal surgery at Seoul St. Mary’s Hospital. He previously served as an attending surgeon at Gwangmyeong Sungae Hospital.
His research covers survivin and HSP90 in colorectal cancer, second primary cancers in patients with gastric cancer, and Borrmann type IV gastric carcinoma. He reported outcomes of laparoscopic totally extraperitoneal inguinal hernia repair in 92 cases. His clinical practice includes cancers and diseases of the stomach, esophagus, and small bowel. He also treats hernias, gallstones and cholecystitis, appendicitis, anal disease, varicose veins, and burns.
Pancreatic cysts under 3 cm without solid components or duct dilation typically undergo active surveillance via MRI or endoscopic ultrasound (EUS). Korean JCI-accredited centers recommend surgery only for suspected malignancy, high-grade dysplasia, or symptomatic cases. Specialist review at tertiary hospitals determines the most appropriate management path.
Bookimed Expert Insight: South Korea ranks 6th globally in our data, reflecting a high volume of complex cases. Seoul National University Bundang Hospital alone treats 1,500,000 patients annually using advanced AI models. This massive data volume allows surgeons to accurately distinguish benign cysts from those requiring robotic surgery. Patients often find that Korean specialists prioritize surveillance over surgery when imaging shows stable, low-risk features.
Patient Consensus: Patients value the fast access to diagnostic scans in Korea. Many note that monitoring is preferred over extensive surgery unless specific red flags like jaundice or weight loss appear.
Korean hospitals perform minimally invasive resections like laparoscopic and robotic pancreatectomy for pancreatic cysts. Surgeons select treatments based on malignancy risk features. These include solid components, jaundice, or cyst growth. Facilities like Severance Hospital utilize advanced imaging and AI to guide these surgical decisions.
Bookimed Expert Insight: Data shows a high concentration of expertise in Seoul at centers like Seoul National University Bundang Hospital. These facilities manage over 1,500,000 patients annually. This massive volume allows surgeons to master robotic techniques for complex pancreatic resections. Patients should prioritize hospitals with KOIHA or Joint Commission International accreditation for better safety outcomes.
Patient Consensus: Patients note that determining if a cyst is precancerous is the most difficult step. They emphasize asking surgeons whether surveillance or immediate removal is safer based on cyst type.
The likelihood of a pancreatic cyst becoming cancerous is generally under 1%. While 30% of cysts have malignant potential, most remain benign. The annual transformation risk is approximately 0.25%. Specialists in South Korea use high-resolution imaging to monitor these growths effectively.
Bookimed Expert Insight: South Korea is home to the first digital hospital globally and maintains several Newsweek-ranked facilities. Centers like Severance Hospital serve 4,000,000 outpatients yearly. This massive volume ensures South Korean specialists identify subtle cyst changes. Their KOIHA-accredited hospitals utilize digital BESTcare systems to track longitudinal imaging data precisely.
Patient Consensus: Patients learn that the specific type of cyst matters more than a single percentage. While many cysts are just monitored, findings like duct involvement or mural nodules are what prompt surgery.